Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

KPTIKPTI
6 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in KARYOPHARM THERAPEUTICS INC

JPMORGAN CHASE & CO holds 207,609 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $2.1M as of 2026-Q2. The position was increased (+440x shares). KPTI represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$2.1M

Current Shares

207,609

Total Value Change

+$1.5M

Total Shares Change

+36,819

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
207,609
+440x
$2.1M0.0%$9.77
42
2026-Q1
Decreased
471
-73.0%
$2,4960.0%$9.13
0
2025-Q4
Increased
1,741
+58.3%
$12,8140.0%$7.31
17
2025-Q3
Decreased
1,100
-99.6%
$7,1940.0%$6.35
0
2025-Q2
Increased
256,443
+50.1%
$1.1M0.0%$4.39
35
2025-Q1
New
170,790
-
$638,7550.0%$4.16
37

Other major holders of KPTI: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used